Loading...
XETR
SRT
Market cap13bUSD
Jun 19, Last price  
181.60EUR
1D
4.85%
1Q
10.60%
Jan 2017
153.21%
Name

Sartorius AG

Chart & Performance

D1W1MN
XETR:SRT chart
P/E
149.28
P/S
3.71
EPS
1.22
Div Yield, %
0.42%
Shrs. gr., 5y
0.17%
Rev. gr., 5y
13.10%
Revenues
3.54b
+4.66%
521,053,000589,027,000611,621,000602,084,000659,317,000733,100,000845,710,000887,269,000891,168,0001,114,752,0001,300,296,0001,404,570,0001,566,034,0001,826,966,0002,335,657,0003,449,222,0004,174,700,0003,395,700,0003,380,700,0003,538,100,000
Net income
155m
+84.40%
29,019,00030,132,00016,282,000975,00031,020,00052,795,00048,510,00052,424,00048,524,000126,303,000102,932,000114,730,000141,342,000218,743,000321,472,000426,978,000913,100,000205,200,00084,000,000154,900,000
CFO
656m
-32.80%
51,715,00033,141,00052,990,000143,364,00096,008,00079,034,00053,163,000103,260,000129,688,000125,362,000170,421,000206,509,000244,524,000377,189,000511,525,000865,814,000734,200,000853,600,000976,200,000656,000,000
Dividend
Mar 28, 20250.73 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Sartorius AG, a German company established in 1870 and based in Göttingen, is a global supplier of innovative bioprocess solutions and laboratory products and services. The company's extensive portfolio supports life science research, biopharmaceutical manufacturing, quality control, and other applied industries worldwide. Its offerings encompass a wide array of sophisticated tools and consumables, including: Advanced Analytics: Biosensors, label-free detection, and SPR systems; live-cell analysis platforms, flow cytometry, and related reagents. Cell Culture and Fermentation: Various bioreactors (e.g., single-use, stainless steel, benchtop) along with specialized media (for antibodies, recombinant proteins, stem cells, viral vaccines) and other essential reagents like buffers and microcarriers. Filtration and Separation: A comprehensive range of membranes, filter papers, syringe filters, and diverse filtration and ultrafiltration devices for sterile processing, sample preparation, and clarification. Laboratory Essentials: Weighing and pipetting systems, centrifuges, industrial microbiology systems, and water purification units. Process Solutions: Fluid management, process chromatography, and advanced analytical technologies coupled with data analytics. Beyond products, Sartorius provides crucial support services such as bioprocess development and engineering, protein expression system services, media and process optimization, testing, instrument services, and validation assistance.
URL
https://www.sartorius.com/
IPO date
Apr 01, 1999
Employees
15,048
Domiciled in
DE
Incorporated in
DE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT